Iradimed (IRMD) Cash from Operations Growth (1y) (2014 - 2026)
Iradimed (IRMD) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 122.43% |
| 10 | Iradimed | 1.22 Bn | 1.16 Bn | 16.81 Mn | 93.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.15% |
| Dec 31, 2025 | -1.07% |
| Sep 30, 2025 | -23.36% |
| Jun 30, 2025 | 16.69% |
| Mar 31, 2025 | 10.53% |
| Dec 31, 2024 | 53.01% |
| Sep 30, 2024 | 554.54% |
| Jun 30, 2024 | 88.93% |
| Mar 31, 2024 | -16.42% |
| Dec 31, 2023 | 28.75% |
| Sep 30, 2023 | -64.64% |
| Jun 30, 2023 | 114.36% |
| Mar 31, 2023 | 225.77% |
| Dec 31, 2022 | -9.72% |
| Sep 30, 2022 | 16.58% |
| Jun 30, 2022 | -54.09% |
| Mar 31, 2022 | 51.23% |
| Dec 31, 2021 | 34.85% |
| Sep 30, 2021 | 153.21% |
| Jun 30, 2021 | 351.65% |